Lindbrook Capital, LLC Sarepta Therapeutics, Inc. Transaction History

Lindbrook Capital, LLC

  • $1.18 Billion
  • Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 167 shares of SRPT stock, worth $17,458. This represents 0.0% of its overall portfolio holdings.

Number of Shares
167
Previous 124 34.68%
Holding current value
$17,458
Previous $19,000 5.26%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
BUY
$124.33 - $156.75 $5,346 - $6,740
43 Added 34.68%
167 $20,000
Q2 2024

Jul 31, 2024
SELL
$113.33 - $163.85 $1,699 - $2,457
-15 Reduced 10.79%
124 $19,000
Q1 2024

Apr 25, 2024
BUY
$93.7 - $141.53 $6,465 - $9,765
69 Added 98.57%
139 $17,000
Q4 2023

Jan 31, 2024
BUY
$67.31 - $124.76 $1,884 - $3,493
28 Added 66.67%
70 $6,000
Q3 2023

Oct 25, 2023
BUY
$102.5 - $123.59 $1,127 - $1,359
11 Added 35.48%
42 $5,000
Q2 2023

Jul 28, 2023
SELL
$106.4 - $157.19 $957 - $1,414
-9 Reduced 22.5%
31 $3,000
Q1 2023

Apr 26, 2023
BUY
$117.53 - $155.99 $1,410 - $1,871
12 Added 42.86%
40 $5,000
Q4 2022

Jan 24, 2023
SELL
$100.86 - $132.13 $2,218 - $2,906
-22 Reduced 44.0%
28 $0
Q3 2022

Nov 10, 2022
BUY
$75.71 - $119.24 $3,785 - $5,962
50 New
50 $6,000
Q1 2022

Apr 21, 2022
SELL
$63.15 - $90.42 $3,094 - $4,430
-49 Closed
0 $0
Q3 2021

Nov 05, 2021
BUY
$65.97 - $92.48 $2,770 - $3,884
42 Added 600.0%
49 $5,000
Q2 2021

Jul 27, 2021
BUY
$69.38 - $86.75 $485 - $607
7 New
7 $1,000
Q1 2021

Apr 28, 2021
SELL
$72.25 - $168.95 $794 - $1,858
-11 Closed
0 $0
Q4 2020

Jan 27, 2021
BUY
$125.56 - $178.74 $1,381 - $1,966
11 New
11 $2,000
Q1 2020

Apr 22, 2020
SELL
$82.38 - $131.64 $12,357 - $19,745
-150 Closed
0 $0
Q4 2019

Jan 27, 2020
SELL
$76.53 - $135.58 $11,479 - $20,337
-150 Reduced 50.0%
150 $19,000
Q3 2019

Oct 31, 2019
BUY
$72.81 - $156.91 $21,843 - $47,073
300 New
300 $23,000
Q2 2019

Jul 24, 2019
SELL
$112.21 - $151.95 $33,663 - $45,585
-300 Closed
0 $0
Q1 2019

Apr 23, 2019
BUY
$106.67 - $151.68 $32,001 - $45,504
300 New
300 $35,000

Others Institutions Holding SRPT

# of Institutions
532
Shares Held
84.5M
Call Options Held
2.06M
Put Options Held
1.52M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $9.15B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email